EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications

Chengliang Liu, Zhijun Tang, Yilin Zhu, Xuanrong Sun iD, Lujuan Xu, Xiangsheng Liu

Small · 2026

DOI: 10.1002/smll.74060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Chengliang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, The "Pioneer" and "Leading Goose" R&D Program of Zhejiang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid aptamers represent a distinctive class of molecular recognition elements with high binding affinity, excellent chemical stability, and low immunogenicity, making them powerful tools for diverse biomedical applications. Nevertheless, monovalent aptamers are often constrained by limited binding avidity, suboptimal pharmacokinetics, and insufficient biological activation. To address these challenges, multivalent aptamers engineered by assembling multiple units in a well‐defined spatial configuration, have emerged to significantly enhance target engagement. This approach improves affinity, specificity, and functional potency, unlocking novel applications inaccessible to monovalent constructs. This review provides a comprehensive overview of recent advances in multivalent aptamer engineering. First, we outline advancements in systematic evolution of ligands by exponential enrichment (SELEX) strategies enabling the direct evolution of multivalent aptamers through rational library design and target‐guided selection. Subsequently, we discuss various design approaches for constructing multivalent architectures, alongside their advantages and limitations. Finally, we highlight representative applications, including targeted delivery, therapeutic intervention, molecular imaging, and diagnostics, which capitalize on the multivalency effect to achieve superior biological outcomes in next‐generation biomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideSELEX Aptamer TechniqueHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

DNA nanotechnologySELEXmultivalency effectmultivalent aptamersprecision therapeuticstargeted drug delivery

Substanzen

Aptamers, Nucleotide

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
  • The Key Laboratory of Zhejiang Province For Basic and Clinical Application of Functional Nucleic Acids, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

ORCID-Profile: Xuanrong Sun

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • The "Pioneer" and "Leading Goose" R&D Program of Zhejiang

Zitieren

APA

Liu, C., Tang, Z., Zhu, Y., Sun, X., Xu, L., & Liu, X. (2026). Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications. Small. https://doi.org/10.1002/smll.74060

Vancouver

Liu C, Tang Z, Zhu Y, Sun X, Xu L, Liu X. Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications. Small. 2026. doi:10.1002/smll.74060

BibTeX
@article{Liu2026,
  author = {Liu, Chengliang and Tang, Zhijun and Zhu, Yilin and Sun, Xuanrong and Xu, Lujuan and Liu, Xiangsheng},
  title = {Multivalent Aptamers: Contemporary Engineering Strategies and Biomedical Applications},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.74060}
}
Kostenlos starten →